These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3114459)

  • 1. Tumor-associated carbohydrate antigens.
    Dabelsteen E; Clausen H
    J Oral Pathol; 1987 Apr; 16(4):196-8. PubMed ID: 3114459
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of fibronectin and laminin in oral leukoplakia and carcinoma.
    Meyer JR; Silverman S; Daniels TE; Kramer RH; Greenspan JS
    J Oral Pathol; 1985 Mar; 14(3):247-55. PubMed ID: 3921680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum beta 2 microglobulin in oral malignancy and premalignancy.
    Scully C
    J Oral Pathol; 1981 Oct; 10(5):354-7. PubMed ID: 6174717
    [No Abstract]   [Full Text] [Related]  

  • 4. Ha-ras oncogene product in human oral squamous cell carcinoma.
    Oku N; Shimada K; Itoh H
    Kobe J Med Sci; 1989 Dec; 35(5-6):277-86. PubMed ID: 2699627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes detected by binding of radiolabelled protein A in patients with oral cancer and oral premalignant lesions.
    Scully C; Barkas T; Boyle P; McGregor IA
    J Clin Lab Immunol; 1982 Jun; 8(2):113-5. PubMed ID: 7108937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytoplasmic receptors of steroid sex hormones in malignant tumors amd precancerous processes of the human oral mucosa].
    Bassalyk LS; Falileev GV; Kushlinskiĭ NE; Nagibin AA
    Vopr Onkol; 1987; 33(1):28-30. PubMed ID: 3811307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of oral cancer tissue for the presence of the proteins ICP 4, ICP 5, ICP 6, ICP 8, and gB of herpes simplex virus type 1.
    Shillitoe EJ; Hwang CB; Silverman S; Greenspan JS
    J Natl Cancer Inst; 1986 Mar; 76(3):371-4. PubMed ID: 2419620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microspectrophotometric determination of DNA in oral lesions.
    Giménez IB; Conti CJ
    J Oral Surg; 1977 Jun; 35(6):465-8. PubMed ID: 266061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characterization of the cell population of oral mucosa tumors and their metastases based on DNA analysis].
    Pape HD; Pfitzer P; Sjerobabin I
    Acta Stomatol Belg; 1975; 72(3):421-3. PubMed ID: 1062143
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of cytokeratin, filaggrin and involucrin profiles in oral leukoplakias and squamous carcinomas.
    Vigneswaran N; Peters KP; Hornstein OP; Haneke E
    J Oral Pathol Med; 1989 Aug; 18(7):377-90. PubMed ID: 2479742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA content in reactive hyperplasia, precancerosis, and carcinomas of the oral cavity. A cytophotometric study.
    Doseva D; Christov K; Kristeva K
    Acta Histochem; 1984; 75(2):113-9. PubMed ID: 6441421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal cancer-associated antigen (GICA) in oral carcinoma.
    Airoldi M; Piantino P; Pacchioni D; Mastromatteo V; Pedani F; Gandolfo S
    Oral Surg Oral Med Oral Pathol; 1986 Mar; 61(3):263-7. PubMed ID: 3458129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and salivary CEA and GICA levels in oral cavity tumours.
    Negri L; Pacchioni D; Calabrese F; Giacomasso S; Mastromatteo V; Fazio M
    Int J Biol Markers; 1988; 3(2):107-12. PubMed ID: 3243976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feulgen microspectrophotometry of oral cancer and leukoplakia.
    Doyle JL; Manhold JH
    J Dent Res; 1975; 54(6):1196-9. PubMed ID: 1059658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo-immunotherapy.
    Ravindranath NM; Nishimoto K; Chu K; Shuler C
    Anticancer Res; 2000; 20(1A):21-6. PubMed ID: 10769630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [S phase fraction and immunohistologic demonstration of the epithelial marker MAM-6 in orofacial tumors].
    Kunz J; Ruschin P; Zotter S
    Zentralbl Allg Pathol; 1986; 132(3):233-42. PubMed ID: 3788316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
    Ravindranath NM; Shuler C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of DNA content in oral carcinoma.
    Sen R
    Int J Biol Markers; 1989; 4(3):174-80. PubMed ID: 2614086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of a new tumor marker for breast carcinoma and ovarian carcinoma].
    Hoffmann L
    Dtsch Med Wochenschr; 1987 May; 112(21):847-9. PubMed ID: 3472869
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of testicular cancer gene expression in samples of oral leukoplakia and squamous cell carcinoma of the mouth].
    Skorodumova LO; Muraev AA; Zakharova ES; Shepelev MV; Korobko IV; Zaderenko IA; Ivanov SIu; Gnuchev NV; Georgiev GP; Larin SS
    Vopr Onkol; 2012; 58(4):486-92. PubMed ID: 23607202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.